Observational studyBMC cancer2021

Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917).

Takahiro Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.